Dr. Bodor, Yvette Uribe and Uma Srikumaran MD, Associate Professor of Orthopedic Surgery and Chief of the Shoulder Service at Johns Hopkins University, have submitted important findings for publication to the Journal of Shoulder and Elbow Surgery. The paper, titled “Resolution of Vaccination Related Shoulder Dysfunction via Ultrasonic Aspiration, a Case Series of 5 Patients,” focuses on the resolution of a vaccination-related medical problem for which there has been no good medical solution.

What is SIRVA?
Vaccinations are one of the greatest medical advances of the 20th century, reducing child mortality by 50% and averting up to 3 million deaths per year. Ensuring public trust and safety in vaccines is more important than ever, which is why extensive testing is performed before a vaccine is released. However, sometimes injuries can occur; the most common injury is known as Shoulder-Injury-Related Vaccine Administration (SIRVA). Fortunately, SIRVA only happens in 1 out of 100,000 injections but accounts for 53% of vaccine-related claims to the national no-fault Vaccine Injury Compensation Program. This can occur when a vaccination is inadvertently injected too high and too deep in the shoulder and therefore deposited into the rotator cuff or shoulder capsule. This causes inflammation and severe pain because the vaccine cannot be cleared from tendons and collagenous structures as normally occurs when injected properly into muscle. The problem can be treated with oral medications, cortisone injections, physical therapy and arthroscopic surgery; however, in two thirds of SIRVA cases, these methods don’t work and patients continue to suffer from chronic pain.

How NMRF is Helping
Dr. Bodor and Enoch Montalvo, RN were the first to describe vaccination-related shoulder dysfunction in 2007. Six months ago, Dr. Bodor came up with a way to use ultrasound to identify the location of the deposited vaccine in patients with SIRVA, then perform an ultra-minimally invasive procedure to aspirate the vaccine and clean out the tendon. Up until this procedure, there was no treatment to help patients with chronic pain as a result of SIRVA. So far, 5 out of 5 patients treated with the new method experienced resolution of their long-lasting pain and disability within 1-2 weeks of the procedure. The NMRF has been following outcomes of these
patients and at 6 months following the procedure, they remain pain-free.


Learn More

  • To learn more about SIRVA, go to: wired.com/2015/09/cases-shoulder-injuries-vaccines-increasing/
    to read the article, “Why Are Cases of Shoulder Injuries From Vaccines Increasing?” from Wired Magazine; the article includes excerpts from interviews with Dr. Marko Bodor and Elizabeth Cassayre from Napa, the first patient to be diagnosed with this condition in 2007.
  • A former fellow of the Bodor Clinic, Naveed Natanzi, MD, recently submitted a paper to the journal Radiology Case Reports based on Dr. Bodor’s original findings, which help clarify why some patients have chronic pain following vaccine administration. We are excited to announce that the paper was just accepted and published to the journal, which is available world-wide for free (open access). NMRF is listed in the acknowledgement. To view the article, go to: ncbi.nlm.nih.gov/pmc/articles/PMC7078120/

 

Dr. Bodor explains SIRVA and its treatment

Dr. Marko Bodor, Director of Research at the Napa Medical Research Foundation, explains what SIRVA is and how to treat it, helping patients with chronic pain get back to living an active lifestyle.

Share This